|Bid||0.5100 x 334700|
|Ask||0.5250 x 1317400|
|Day's range||0.4900 - 0.5250|
|52-week range||0.4900 - 1.3750|
|Beta (5Y monthly)||1.04|
|PE ratio (TTM)||N/A|
|Earnings date||20 Feb 2023 - 24 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||25 Mar 1988|
|1y target est||0.95|
Shareholders of Starpharma Holdings Limited ( ASX:SPL ) will have been dismayed by the negative share price return over...
An antiviral barrier nasal spray called VIRALEZE™ will launch in Hong Kong and Macau in the coming weeks, following a recent sales and distribution agreement between the product's developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited.
To get a sense of who is truly in control of Starpharma Holdings Limited ( ASX:SPL ), it is important to understand the...